Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu-Shan Liu

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|July 16, 2021
A promising field: regulating imbalance of EndMT in cardiovascular diseasesKun Zhou, Kai-Jiang Tian, Bin-Jie Yan, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology|December 16, 2010
[Changes of scavenger receptor class B type I and peroxisome proliferator-activated receptor gamma expression in atherosclerotic mini swine]Guang-Hui Yi, Zhong-Cheng Mo, Ying Zeng, et al.
Biomedical Reports|March 21, 2014
The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review)Qi Wu, Zhi-Han Tang, Juan Peng, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2017
PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling PathwayLu-Shan Liu, Xue-Qin Bai, Ya Gao, et al.
Sheng Li Xue Bao : [Acta Physiologica Sinica]|December 25, 2007
[Concentration polarization of low density lipoprotein at the distal end of carotid stenosis promotes atherogenesis]Dang-Heng Wei, Gui-Xue Wang, Chao-Jun Tang, et al.
Atherosclerosis|December 13, 2017
TM6SF2: A novel target for plasma lipid regulationTing-Ting Li, Tao-Hua Li, Juan Peng, et al.
Cardiovascular Drugs and Therapy|February 25, 2020
Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular DiseasesWen Luo, Dan-Dan Gui, Bin-Jie Yan, et al.
Frontiers in Pharmacology|August 12, 2017
TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H<sub>2</sub>S SystemJuan Peng, Zhi-Han Tang, Zhong Ren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 5, 2018
PCSK9: A potential regulator of apoE/apoER2 against inflammation in atherosclerosis?Xue-Qin Bai, Juan Peng, Mei-Mei Wang, et al.
Current Medicinal Chemistry|March 7, 2020
The Role of Ubiquitin E3 Ligase in AtherosclerosisZhi-Xiang Zhou, Zhong Ren, Bin-Jie Yan, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|July 16, 2021
A promising field: regulating imbalance of EndMT in cardiovascular diseasesKun Zhou, Kai-Jiang Tian, Bin-Jie Yan, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology|December 16, 2010
[Changes of scavenger receptor class B type I and peroxisome proliferator-activated receptor gamma expression in atherosclerotic mini swine]Guang-Hui Yi, Zhong-Cheng Mo, Ying Zeng, et al.
Biomedical Reports|March 21, 2014
The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review)Qi Wu, Zhi-Han Tang, Juan Peng, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2017
PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling PathwayLu-Shan Liu, Xue-Qin Bai, Ya Gao, et al.
Sheng Li Xue Bao : [Acta Physiologica Sinica]|December 25, 2007
[Concentration polarization of low density lipoprotein at the distal end of carotid stenosis promotes atherogenesis]Dang-Heng Wei, Gui-Xue Wang, Chao-Jun Tang, et al.
Atherosclerosis|December 13, 2017
TM6SF2: A novel target for plasma lipid regulationTing-Ting Li, Tao-Hua Li, Juan Peng, et al.
Cardiovascular Drugs and Therapy|February 25, 2020
Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular DiseasesWen Luo, Dan-Dan Gui, Bin-Jie Yan, et al.
Frontiers in Pharmacology|August 12, 2017
TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H<sub>2</sub>S SystemJuan Peng, Zhi-Han Tang, Zhong Ren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 5, 2018
PCSK9: A potential regulator of apoE/apoER2 against inflammation in atherosclerosis?Xue-Qin Bai, Juan Peng, Mei-Mei Wang, et al.
Current Medicinal Chemistry|March 7, 2020
The Role of Ubiquitin E3 Ligase in AtherosclerosisZhi-Xiang Zhou, Zhong Ren, Bin-Jie Yan, et al.
Pageof 4